EN HU

Király Róbert

Name: Király Róbert
Affiliation:
  • Debreceni Egyetem. Általános Orvostudományi Kar. Biokémiai és Molekuláris Biológiai Intézet / University of Debrecen. Faculty of Medicine. Department of Biochemistry and Molecular Biology
Degree:
  • PhD, Debreceni Egyetem (2008)
  • Habilitáció, Debreceni Egyetem (2023)

Publication list

Uploaded publications:
37
Publications in DEA:
37
OA:
14
Date range:
2004-2025
2025
1.
Korponay-Szabó, I., Király, R., Gyimesi, J., Mäki, M.: Development of Cell-Assembled Human Endomysial-Type Biomatrix Substrate for the Detection of Celiac Disease Autoantibodies.
Int. J. Mol. Sci. 26 (3), 1-18, (article identifier: 1012), 2025.
Journal metrics:
Q2 Catalysis (2024)
Q1 Computer Science Applications (2024)
Q1 Inorganic Chemistry (2024)
Q1 Medicine (miscellaneous) (2024)
Q2 Molecular Biology (2024)
D1 Organic Chemistry (2024)
Q1 Physical and Theoretical Chemistry (2024)
D1 Spectroscopy (2024)
2.
Csaholczi, B., Csuth, A. R., Korponay-Szabó, I., Fésüs, L., Király, R.: Transglutaminase 2 is an RNA-binding protein: experimental verification and characterisation of a novel transglutaminase feature.
FEBS J. 292 (4), 915-928, 2025.
Journal metrics:
D1 Biochemistry (2024)
Q1 Cell Biology (2024)
Q1 Molecular Biology (2024)
2023
3.
Garabuczi, É., Tarban, N., Vincze-Fige, É., Patsalos, A., Halász, L., Szendi-Szatmári, T., Sarang, Z., Király, R., Szondy, Z.: Nur77 and PPARγ regulate transcription and polarization in distinct subsets of M2-like reparative macrophages during regenerative inflammation.
Front. Immunol. 14, 1-14, (article identifier: 1139204), 2023.
Journal metrics:
Q1 Immunology
Q1 Immunology and Allergy
2021
4.
Csobán-Szabó, Z., Bécsi, B., El Alaoui, S., Fésüs, L., Korponay-Szabó, I., Király, R.: Biochemical Characterisation of Human Transglutaminase 4.
Int. J. Mol. Sci. 22 (22), 1-18, 2021.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
5.
Molnár, T., Pallagi, P., Tél, B., Király, R., Csoma, E., Jenei, V., Varga, Z., Gogolák, P., Odile Hueber, A., Máté, Z., Erdélyi, F., Szabó, G., Pettkó-Szandtner, A., Bácsi, A., Virág, L., Maléth, J., Koncz, G.: Caspase-9 acts as a regulator of necroptotic cell death.
FEBS J. 288 (22), 6476-6491, 2021.
Journal metrics:
Q1 Biochemistry
Q1 Cell Biology
Q1 Molecular Biology
6.
Diós, Á., Elek, R., Szabó, I., Horváth, S., Gyimesi, J., Király, R., Werkstetter, K., Koletzko, S., Fésüs, L., Korponay-Szabó, I.: Gamma-gliadin specific celiac disease antibodies recognize p31-43 and p57-68 alpha gliadin peptides in deamidation related manner as a result of cross-reaction.
Amino Acids. 53 (7), 1051-1063, 2021.
Journal metrics:
Q2 Biochemistry
Q2 Clinical Biochemistry
Q2 Organic Chemistry
7.
Shaw, A., Bartáné Tóth, B., Király, R., Arianti, R., Csomós, I., Póliska, S., Vámos, A., Korponay-Szabó, I., Bacsó, Z., Győry, F., Fésüs, L., Kristóf, E.: Irisin stimulates the release of CXCL1 from differentiating human subcutaneous and deep-neck derived adipocytes via upregulation of NF[kappa]B pathway.
Front. Cell. Dev. Biol. 9, 1-19, 2021.
Journal metrics:
Q1 Cell Biology
Q1 Developmental Biology
2020
8.
Csobán-Szabó, Z., Fésüs, L., Király, R.: Protein-peptide based assay for the characterization of human blood coagulation factor XIII-A isopeptidase activity.
Anal. Biochem. 600, 1-8, 2020.
Journal metrics:
Q3 Biochemistry
Q2 Biophysics
Q3 Cell Biology
Q3 Molecular Biology
9.
Ulukan, B., Bihorac, A., Sipahioglu, T., Király, R., Fésüs, L., Telci, D.: Role of Tissue Transglutaminase Catalytic and Guanosine Triphosphate-Binding Domains in Renal Cell Carcinoma Progression.
ACS Omega. 5 (43), 28273-28284, 2020.
Journal metrics:
Q1 Chemistry (miscellaneous)
Q1 Chemical Engineering (miscellaneous)
2019
10.
Aladdin, A., Király, R., Botó, P., Regdon, Z., Tar, K.: Juvenile Huntington's disease skin fibroblasts respond with elevated parkin level and increased proteasome activity as a potential mechanism to counterbalance the pathological consequences of mutant huntingtin protein.
Int. J. Mol. Sci. 20 (21), 1-39, 2019.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
Q1 Spectroscopy
11.
Sivadó, É., El Alaoui, M., Király, R., Fésüs, L., Delolme, F., Page, A., El Alaoui, S.: Optimised methods (SDS/PAGE and LC-MS) reveal deamidation in all examined transglutaminase-mediated reactions.
FEBS Open Bio. 9 (2), 396-404, 2019.
Journal metrics:
Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)
2018
12.
Fésüs, L., Király, R.: Transzglutamináz.
In: Ezerarcú fehérjék. Szerk.: Buday László, Nyitray László, Perczel András, Semmelweis Kiadó, Budapest, 737-748, 2018. ISBN: 9789633314586
2017
13.
Thangaraju, K., Király, R., Mótyán, J. A., Ambrus, V. A., Fuxreiter, M., Fésüs, L.: Computational analyses of the effect of novel amino acid clusters of human transglutaminase 2 on its structure and function.
Amino Acids. 49, 605-614, 2017.
Journal metrics:
Q2 Biochemistry
Q1 Clinical Biochemistry
Q1 Organic Chemistry
14.
Thangaraju, K., Király, R., Demény, M. Á., Mótyán, J. A., Fuxreiter, M., Fésüs, L.: Genomic variants reveal differential evolutionary constraints on human transglutaminases and point towards unrecognized significance of transglutaminase 2.
PLoS One. 12 (3), 1-24, 2017.
Journal metrics:
Q1 Agricultural and Biological Sciences (miscellaneous)
Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q1 Medicine (miscellaneous)
15.
Szondy, Z., Korponay-Szabó, I., Király, R., Sarang, Z., Tsay, G. J.: Transglutaminase 2 in human diseases.
Biomedicine (Taipei). 7 (3), [1-13], 2017.
Journal metrics:
Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q2 Medicine (miscellaneous)
2016
16.
Király, R., Thangaraju, K., Nagy, Z., Collighan, R., Nemes, Z., Griffin, M., Fésüs, L.: Isopeptidase activity of human transglutaminase 2: disconnection from transamidation and characterization by kinetic parameters.
Amino Acids. 48 (1), 31-40, 2016.
Journal metrics:
Q2 Biochemistry
Q1 Clinical Biochemistry
Q1 Organic Chemistry
17.
Biri, B., Kiss, B., Király, R., Schlosser, G., Láng, O., Kőhidai, L., Fésüs, L., Nyitray, L.: Metastasis-associated S100A4 is a specific amine donor and an activity-independent binding partner of transglutaminase-2.
Biochem. J. 473 (1), 31-42, 2016.
Journal metrics:
D1 Biochemistry
Q1 Cell Biology
Q1 Molecular Biology
18.
Thangaraju, K., Biri, B., Schlosser, G., Kiss, B., Nyitray, L., Fésüs, L., Király, R.: Real-time kinetic method to monitor isopeptidase activity of transglutaminase 2 on protein substrate.
Anal. Biochem. 505, 36-42, 2016.
Journal metrics:
Q3 Biochemistry
Q2 Biophysics
Q3 Cell Biology
Q3 Molecular Biology
2015
19.
Korponay-Szabó, I., Kerekes-Tóth, B., Gyimesi, J., Bartáné Tóth, B., Kissné Bogáti, R., Király, R., Caja, S., Nadalutti, C., Lindfors, K., Mäki, M., Fésüs, L.: Search for gluten non-dependent prospective biomarkers for in vitro diagnostic use: 16th International Coeliac Disease Symposium 21-24 June 2015, Prague.
2013
20.
Kanchan, K., Ergülen, E., Király, R., Simon-Vecsei, Z., Fuxreiter, M., Fésüs, L.: Identification of a specific one amino acid change in recombinant human transglutaminase 2 that regulates its activity and calcium sensitivity.
Biochem. J. 455 (3), 261-272, 2013.
Journal metrics:
D1 Biochemistry
Q1 Cell Biology
Q1 Molecular Biology
21.
Tóth, B., Kissné Bogáti, R., Király, R., Simon-Vecsei, Z., Caja, S., Bartáné Tóth, B., Nadalutti, C., Lindfors, K., Mäki, M., Fésüs, L., Korponay-Szabó, I.: Lipoma-preferred partner protein (LPP), a genetic marker for coeliac disease predisposition is interacting with transglutaminase 2.
JPGN. 56 (Suppl_2), 200, 2013.
22.
Tóth, B., Kissné Bogáti, R., Király, R., Simon-Vecsei, Z., Caja, S., Bartáné Tóth, B., Nadalutti, C., Lindfors, K., Mäki, M., Fésüs, L., Korponay-Szabó, I.: Lipoma-preferred partner protein (LPP), a genetic marker for coeliac disease predisposition is interacting with transglutaminase 2: 46th Annual Meeting of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN).
23.
Király, R., Barta, E., Fésüs, L.: Polymorphism of transglutaminase 2: unusually low frequency of genomic variants with deficient functions.
Amino Acids. 44 (1), 215-225, 2013.
Journal metrics:
Q2 Biochemistry
Q1 Clinical Biochemistry
Q1 Organic Chemistry
2012
24.
Simon-Vecsei, Z., Király, R., Bagossi, P., Tóth, B., Dahlbom, I., Caja, S., Csősz, É., Lindfors, K., Sblattero, D., Nemes, É., Mäki, M., Fésüs, L., Korponay-Szabó, I.: A single conformational transglutaminase 2 epitope contributed by three domains is critical for celiac antibody binding and effects.
PNAS USA 109 (2), 431-436, 2012.
Journal metrics:
D1 Multidisciplinary
2011
25.
Király, R., Demény, M. Á., Fésüs, L.: Protein transamidation by transglutaminase 2 in cells: a disputed Ca2+ -dependent action of a multifunctional protein.
FEBS J. 278 (24), 4717-4739, 2011.
Journal metrics:
Q1 Biochemistry
Q2 Cell Biology
Q2 Molecular Biology
DEENK University of Debrecen
© 2012 University of Debrecen